Projects per year
Personal profile
Personal profile
Dr. Rudra Pangeni earned his bachelor's degree in Pharmaceutical Sciences from Pokhara University, Nepal, his master's degree in Pharmaceutical Sciences (Pharmaceutics) from Jamia Hamdard University, India, and his doctoral degree in Pharmaceutics from Mokpo National University, South Korea. He completed postdoctoral training in the Nanotherapeutics Lab in the Department of Pharmaceutics at Virginia Commonwealth University (VCU) School of Pharmacy, where he later joined the faculty as a Research Assistant Professor.
His research has been recognized through multiple federal and institutional research awards. He is an inventor on more than five pending patent applications or awarded patents. Dr. Pangeni has also authored numerous peer-reviewed publications, review articles, and book chapters in leading journals. Dr. Pangeni is an active mentor, collaborator, and invited speaker dedicated to advancing pharmaceutical sciences while training the next generation of scientists.
Research interests
Dr. Pangeni specializes in the design and optimization of advanced drug delivery systems to overcome biological barriers and enhance therapeutic outcomes. His research focuses on formulation strategies for ocular, pulmonary, oncologic, topical, and neuropathic pain disorders, with an emphasis on translating innovative formulations into clinically meaningful therapies.
Related documents
Education/Academic qualification
Pharmaceutics, PhD, Mokpo National University
2015 → 2019
Pharmaceutics, MSPS, Jamia Hamdard University
2012 → 2014
Pharmaceutical Sciences, BSPS, Pokhara University
2007 → 2011
-
Fenofibrate microemulsion for treating nitrogen mustard induced corneal injury
Pangeni, R. (CoI)
9/15/25 → 5/30/30
Project: Research project
-
High dose acetaminophen with fomepizole and n-acetylcysteine rescue for treatment of advanced malignancies
Pangeni, R. (CoI)
9/21/23 → 9/20/26
Project: Research project
-
High dose acetaminophen with fomepizole and n-acetylcysteine rescue for treatment of advanced malignancies
Pangeni, R. (PI)
10/1/24 → 9/30/25
Project: Research project
-
A long-acting nanoparticle therapy for treating nitrogen mustard induced corneal injury
Han, S., Poudel, S., Kaffash, E., Zhao, L., Pangeni, R. & Xu, Q., 2026.Research output: Contribution to conference › Presentation
-
A new microemulsion eyedrop for treating nitrogen mustard induced corneal injury
Xu, Q., Kaffash, E., Pangeni, R., Liang, W., Poudel, S. & Ma, J.-X. J., Jun 2026, In: Investigative Ophthalmology and Visual Science. 67, p. 2945Research output: Contribution to journal › Meeting abstract
-
A systematic approach to develop and characterize a compositionally equivalent buprenorphine in situ forming implant (Sublocade®)
Poudel, S., Pangeni, R., Huo, Z., Farkas, D., Gulec, S., Zhang, Q., Lasaosa, M., Tong, R., Moeller, F. G., Li, Q., Wang, Y., Qin, B., Halquist, M. S. & Xu, Q., May 10 2026, In: Journal of controlled release : official journal of the Controlled Release Society. 393, p. 114793Research output: Contribution to journal › Article › peer-review
-
Fenofibrate Loaded Microemulsion for Improving Diabetic Corneal Wound Healing
Kaffash, E., Liang, W., Pangeni, R., Poudel, S., Ma, J.-X. J. & Xu, Q., Jun 2026, In: Investigative Ophthalmology and Visual Science. 67, p. 2113Research output: Contribution to journal › Meeting abstract
-
Fenofibrate microemulsion eyedrops for treating nitrogen mustard induced corneal injury
Kaffash, E., Pangeni, R., Liang, W., Poudel, S., Zhao, L., Ma, J.-X. & Xu, Q., Mar 10 2026, In: Journal of controlled release : official journal of the Controlled Release Society. 391, p. 114656Research output: Contribution to journal › Article › peer-review
Activities
- 2 Membership of network
-
American Association of Pharmaceutical Scientists (External organization)
Pangeni, R. (Chair)
1970 → …Activity: Membership › Membership of network
-
Controlled Release Society (External organization)
Pangeni, R. (Member)
1970 → …Activity: Membership › Membership of network